CHM Cannabis
Home > Boards > US OTC > Medical - Equipment >

Lifeline Biotechnologies, Inc. (LLBO)

Add LLBO Price Alert      Hide Sticky   Hide Intro
Moderator: Wrestler, Arnie1, The Grinch, MEAD II, rmilman
Search This Board: 
Last Post: 12/11/2018 7:13:08 PM - Followers: 274 - Board type: Free - Posts Today: 0

Lifeline Biotechnologies Provides Information To The Public And Its Shareholders

Cyrcadia, Inc. – 2017 Year End and 2018 Look Forward Newsletter

by admin | Feb 21, 2018 | NewsFebruary 27, 2018 Cyrcadia, Inc. (“CI”) extends its thanks and appreciation in your interest and support of our endeavors. We are taking this opportunity to provide an update, as well as apprise you of upcoming expectations. License and Cooperation Agreement with Cyrcadia Asia (“CA”) – Status Earlier in 2017 CI entered into an Agreement with CA, whereby CA assumed the responsibility and funding of the design, development and delivery of a scalable, commercializable iTBra™ system including upgraded hardware and the full suite of application software as well as automation of our proprietary Artificial Intelligence Analytics. The estimated cost of development with Jabil and Mobile Now is approximately $1.2 to $1.5 million US. As such, the agreement calls for CA to provide timely reporting and status of product development including timelines, milestones and dates of completion and delivery of product (market readiness, product volume availability and delivery terms and schedules). Many strides have been made in the evolution of the relationship as CA has established its operations, initial staffing and funding. Both CI and CA are in a mode of cooperation, as called for by the Agreement and, presently, both entities are to hold routine meetings where comprehensive updating and reporting will be delivered to CI, enabling implementation of our business, operations and marketing plans. We will be reporting the outcomes of that meeting to move forward on our ability to commercialize the iTBra™ system this year. Given the above, we would like to update on the internal operations that will allow for CI to “hit the ground running” upon product delivery. Status of Product Development and Manufacturing Under CA’s...

Welcome to Lifeline Biotechnologies Inc. (LLBO) Board!!!

Clinical Trial

In Progress - To Be Completed

** Funding for Clinical Trial

** Vendor delivery of testing materials

Completed for Clinical Trial

** Protocol for testing accepted

** Internal Review Board (IRB) approved

** Contract with hospital executed

Prospective Partner

** Stanford University's Canary Research

Research in blood genomics


The Mastascope is an ultraslim, hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast. Because many cancers actually begin within an individual milk duct, these intraductal tumors are visualized easily and can be biopsied. This product has been used in leading breast centers in the United Kingdom and other countries with great success. Lifeline has obtained a CE mark for marketing and distribution in Europe. 


Lifeline has developed and tested an ultraslim endoscope to directly visualize the ovarian surface in the search for cancer. This is of great advantage to physicians, because neither MRI, X-Ray nor Ultrasonography can provide accurate assessments of subtle surface changes. Initial reports of clinical usage have been encouraging.

About $LLBO - Lifeline Biotechnologies, Inc.

About Lifeline Biotechnologies:

Lifeline Biotechnologies, Inc. (OTC Market: LLBO) founded in 1994 is based in Reno, NV.  LLBO has invested over $10M in a device and process for early detection of breast tissue abnormalities some of which are cancerous or pre-cancer.  Three “Proof of Concept” clinical trials of over 500 women have been completed and three patents (one hardware, two software) have been awarded. 

Safe Harbor:

This publication includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, the ability to obtain financing, successful development of the Company's product or market acceptance of the product and regulatory and shareholder approval for anticipated actions. became Cyrcadia Health

$LLBO is Cyrcadia's largest shareholder at approximately 40%

Transfer Agent

OTC Corporate Transfer Service Co.
52 Maple Run Drive
Jericho, NY 11753

Share Structure
Shares Outstanding 3,026,680,967 a/o Sep 30, 2014
Float 650,000,000 a/o Jun 30, 2009
Authorized Shares 4,950,000,000 a/o Sep 30, 2014
Par Value 0.001

Company Information

About Lifeline Biotechnologies:

Lifeline Biotechnologies, Inc. (OTC Market: LLBO) founded in 1994 is based in Reno, NV.  LLBO has invested over $10M in a device and process for early detection of breast tissue abnormalities some of which are cancerous or pre-cancer.  Three “Proof of Concept” clinical trials of over 500 women have been completed and three patents (one hardware, two software) have been awarded.

About Cyrcadia Health

Cyrcadia Health founded in 2008, is based in Reno, Nev. The Cyrcadia Health product line is a device and software service that detects breast tissue abnormalities leading to health risk assessment and management including early breast cancer identification. Three clinical trials with over 650 participants have achieved proof of concept and superior outcomes when compared to other diagnostic protocols. Cyrcadia Health technology is exclusively licensed for development, manufacturing and marketing worldwide from Lifeline Biotechnologies, Inc (OTC Market: LLBO). Cyrcadia Health is planning a final, limited clinical trial and a 510k device classification to validate the fourth generation of the FWS product. Cyrcadia Health is preparing to apply for a Euro CE Mark to market in the European Union and Asia Pacific markets. See Cyrcadia Health video, “Breast Cancer Tumor Progression” at

iTBra in the News

ABC 7 News - February 5, 2015


ABC 7 News - February 5, 2015

ABC 7 News - January 30, 2015

Good Monring America apperance coming....
Quote from the March 12, 2015 PR

They also interviewed Rob Royea (Cyrcadia's President) for a feature story on Good Morning America expected to air in the next coming months.

Could a Bra Actually Detect Breast Cancer?
By Smithsonian Magzine



Documentary Movie: Detected coming....
Funded by Cisco
Detected Trailer...

Detected trailer on Cisco's facebook page
Detected: Behind the Scenes with Ironbound Films
Meet Chief Evangelist Behind Cancer-Detecting iTBra, Rob Royea

How the Internet of Everything is Changing Healthcare

Can the IoE Save Lives? Connected Bra Could Predict Cancer
By: Cisco's Senior Vice President and Chief Marketing Officer

Detected Website
Detected Facebook
Detected Twitter

Partnered with Flextronics

Cyrcadia Health Partners

In Israel at Flextronics


iTBra Already Saved Nedra Lindsay's Life - See Her Story

Final Clinical Trials, FDA plans and other info from - March 12, 2015 Press Release

...Cyrcadia prepares to enter the final clinical trials that will be conducted at El Camino Hospital (ECH) in Mountain View, CA and the Ohio State University (OSU) Oncology Hospital in Columbus, OH. The trials have been approved through Investigational Review Boards (IRB's) of ECH and are currently undergoing the review process at OSU. The ECH trial is slated for start before the end of April 2015. The trials are expected to be completed in four to 6 months. On completion Cyrcadia will obtain CE Marking allowing for sales and marketing outside of the USA. On completion of the trials Cyrcadia will be submitting a 510(k) to the FDA. Post clearance, marketing will begin in the USA. International sales are expected in Q4 of 2015 and US sales in Q1 or Q2 of 2016.


It is interesting to note that Dr. Farrar at OSU will be the primary investigator for the trials conducted at OSU. Dr. Farrar headed the original "proof of concept" study that was conducted at OSU.


Stanford University Canary Center for Early Cancer Detection has pledged $187,000 to help fund the equipment for the trials at El Camino Hospital.


They also interviewed Rob Royea (Cyrcadia's President) for a feature story on Good Morning America expected to air in the next coming months.


Detected Movie Youtube channel
Video News Clipping ABC7 Los Angeles Health News - Breast Cancer Detecting Bra
Detected: Behind the Scenes with Ironbound Films
Wearable & Social Breast Cancer Screening
Meet Chief Evangelist Behind Cancer-Detecting iTBra, Rob Royea
How the Internet of Everything is Changing Healthcare
GameChanger of the Year: Cyrcadia

$LLBO infograph, DD in a nutshell

CHM Cannabis
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
#27007   Exactly! It's not a game changer as cyrcadia pretends PharrmaBro 11/05/18 02:24:50 PM
#27446  Sticky Note LLBO NEW INVESTOR INFORMATION MEAD II 12/10/18 01:27:26 PM
#25922  Sticky Note “New”Investor Information: confirm 07/17/18 08:30:45 AM
#27480   I’m sure he’s here getting a sniff, every confirm 12/11/18 07:13:08 PM
#27479   Well, what's sadly funny is that he was SquirrelCage 12/11/18 05:01:15 PM
#27478   He should be...And his hard dedicated hours of confirm 12/11/18 04:50:04 PM
#27477   I see Mr. Wowza is still posting on SquirrelCage 12/11/18 04:31:01 PM
#27476   Yes the 5 wearables, hey check this out confirm 12/11/18 04:13:50 PM
#27475   Nice! Let us know if you get any SquirrelCage 12/11/18 03:23:50 PM
#27474   Absolutely, that Mex device a complete fraud in confirm 12/11/18 02:58:38 PM
#27473   At least when you read through the Higia SquirrelCage 12/11/18 02:44:33 PM
#27472   Ahhh, man! Nice piece but when you click SquirrelCage 12/11/18 02:40:43 PM
#27471   And Again —Wearables 12/11/18 confirm 12/11/18 02:34:09 PM
#27470   And speaking of stagnant time... SquirrelCage 12/11/18 02:13:04 PM
#27469   Lots of time jonsmile 12/11/18 02:05:17 PM
#27468   i have time leprisonnier 12/11/18 02:02:19 PM
#27467   OMG! Huggggggge week so far! -.0004. 9yrswaiting 12/11/18 01:07:31 PM
#27466   iFlytech originall News Letter announcement of Cyrcadia interest, confirm 12/11/18 09:53:38 AM
#27465   Also over 400M shares (12%+) are held by MEAD II 12/11/18 09:46:03 AM
#27464   thank you! Fiesta11 12/11/18 09:42:04 AM
#27463   According to the LLBO 3Q Financials 3.3BN shares. MEAD II 12/11/18 09:38:48 AM
#27462   Anyone able to get a accurate float on Fiesta11 12/11/18 09:29:44 AM
#27461   Cyrcadia Asia CEO Rob Royea (Formally Cyrcadia Health confirm 12/11/18 09:13:53 AM
#27460   You are most welcome. I am working on MEAD II 12/11/18 09:02:30 AM
#27459   MEAD II : Thanks for the info. Arnie1 12/11/18 08:58:00 AM
#27458   These are numbers that often fluctuate before the MEAD II 12/11/18 08:48:36 AM
#27457   MEADII: Great compilation! I have been here over Arnie1 12/11/18 08:24:01 AM
#27456   Today at 7:50 am, Bid is .0018 and Arnie1 12/11/18 07:50:39 AM
#27455   Thanks for the informative article, SC... hadn't seen it!! notshakenorstirred 12/10/18 08:13:59 PM
#27454   That's a fair point. However IMHO, significant movement MEAD II 12/10/18 07:08:03 PM
#27453   Agree, 3% of O/S may not be a confirm 12/10/18 06:25:48 PM
#27452   Another day of nothing volume with Billings outstanding jonsmile 12/10/18 05:35:07 PM
#27451   Thank you SC This is an interesting article MEAD II 12/10/18 05:25:30 PM
#27450   Not sure if this article from a couple SquirrelCage 12/10/18 04:27:43 PM
#27449   GREAT NEWS!! MEAD II 12/10/18 03:46:53 PM
#27448 yaro1 12/10/18 03:32:28 PM
#27447   Nice post Mead, certainly one Dec I confirm 12/10/18 02:27:51 PM
#27445   I think you are correct the cost of MEAD II 12/10/18 11:36:52 AM
#27444   I loaded some more! Things are looking good imo! Arnie1 12/10/18 11:16:55 AM
#27443   LLBO..anything’s can happen ... Macmoney 12/10/18 10:33:51 AM
#27442   Very confident that this stock will hit .004 Arnie1 12/10/18 10:17:04 AM
#27441   LLBO...I agree.... Macmoney 12/10/18 10:13:35 AM
#27440   LLBO...chirp.... Not a bad thing . Macmoney 12/10/18 10:08:37 AM
#27439   Side-liners still lurking on here. Chaka 12/10/18 10:04:09 AM
#27438   Quiet trading zino 12/10/18 10:01:54 AM
#27436   Exactly it’s a Game changer, utilizing most advanced confirm 12/10/18 08:20:30 AM
#27435   LLBO..Looking forward to a great week all. Macmoney 12/10/18 12:00:43 AM
#27434   Well, even the grinches heart grew 3 sizes Wrestler 12/09/18 10:06:08 PM
#27433   Launch announcement exerts: confirm 12/09/18 09:37:55 PM
#27432   Re-Post: New investors: A women with the odds confirm 12/09/18 09:32:18 PM
#27431 pls.. mark5050 12/09/18 05:52:58 PM
#27428   I meant for your insight, Chaka. I know Wrestler 12/09/18 11:38:18 AM